GenoFocus Inc (187420) — Financial Flexibility Index
GenoFocus Inc (187420) has a Financial Flexibility Index of 0.01x as of December 2025. Free cash flow of ₩426.97 Million (operating CF ₩288.09 Million minus capex ₩138.88 Million) represents 0% of total liabilities (₩81.08 Billion). Also explore 187420 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GenoFocus Inc Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for GenoFocus Inc across 12 annual periods. Check GenoFocus Inc (187420) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for GenoFocus Inc (2014–2025)
Year-by-year free cash flow to debt coverage for GenoFocus Inc. For the full company profile including market capitalisation, see GenoFocus Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | ₩4.58 Billion | ₩3.50 Billion | ₩81.08 Billion | ▲ +93.9% |
| 2024 | 0.03x | ₩3.57 Billion | ₩2.87 Billion | ₩122.49 Billion | ▲ +159.8% |
| 2023 | -0.05x | ₩-3.48 Billion | ₩-4.82 Billion | ₩71.50 Billion | ▼ -1269.2% |
| 2022 | 0.00x | ₩-391.36 Million | ₩-4.71 Billion | ₩110.02 Billion | ▼ -104.3% |
| 2021 | 0.08x | ₩6.96 Billion | ₩-2.39 Billion | ₩83.24 Billion | ▼ -48.3% |
| 2020 | 0.16x | ₩11.88 Billion | ₩-2.45 Billion | ₩73.46 Billion | ▼ -25.5% |
| 2019 | 0.22x | ₩8.26 Billion | ₩-167.50 Million | ₩38.08 Billion | ▼ -75.5% |
| 2018 | 0.89x | ₩8.98 Billion | ₩1.56 Billion | ₩10.12 Billion | ▲ +53.5% |
| 2017 | 0.58x | ₩3.43 Billion | ₩1.36 Billion | ₩5.93 Billion | ▼ -93.1% |
| 2016 | 8.42x | ₩5.98 Billion | ₩516.09 Million | ₩709.87 Million | ▼ -43.6% |
| 2015 | 14.94x | ₩11.00 Billion | ₩2.85 Billion | ₩736.18 Million | ▲ +2374.9% |
| 2014 | 0.60x | ₩4.39 Billion | ₩-286.45 Million | ₩7.28 Billion | — |